- Generic name
- Elagolix
- Strength
- 150 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Orili 150 Tablet
About Orili 150 Tablet
Orili 150 is a 150 mg tablet made by Square Pharmaceuticals PLC. It contains elagolix, a gonadotropin-releasing hormone (GnRH) antagonist, and is used for the management of moderate to severe pain linked to endometriosis.
There are 8 brands of Elagolix listed in Bangladesh. The lowest listed price is Elagox 150 mg Tablet at ৳ 170.00 per unit.
What is Orili 150 Tablet?
Orili 150 is an oral tablet containing 150 mg of elagolix. Elagolix belongs to the gonadotropin-releasing hormone (GnRH) antagonist class of medicines. Endometriosis happens when tissue similar to the lining of the uterus grows outside it, which can cause pain during periods, pelvic pain between periods and pain during sex. These growths depend on the hormone estrogen, and elagolix works against the GnRH receptor to reduce that hormone-driven growth. Orili 150 is used for the management of moderate to severe pain associated with endometriosis. Only a registered doctor can decide whether it is suitable for a particular woman.
Uses of Orili 150
Orili 150 is used for the management of moderate to severe pain associated with endometriosis in women. Endometriosis is a condition in which tissue similar to the uterine lining grows outside the uterus, often on the ovaries, fallopian tubes or areas around the uterus. This can lead to pain during periods, pelvic pain between periods and pain during sexual intercourse. The medicine targets the GnRH receptor, which is involved in the estrogen-dependent growth of these lesions. It is not a treatment for other types of pain.
How to use Orili 150
Orili 150 is taken by mouth. The doctor decides the dose, the number of times a day it is taken and how long the course lasts; those details are not fixed here. The tablet is usually taken at about the same time each day, with or without food. Pregnancy should be excluded before starting, or treatment started within the first days of a menstrual period. Do not change the schedule on your own. Ask your doctor or pharmacist if you are unsure about how to take it.
Side effects of Orili 150
Common side effects reported with elagolix include hot flushes and night sweats, headache, nausea, insomnia, missed periods (amenorrhea), anxiety, joint pain, and depression-related reactions or mood changes. Some people may notice other effects. Because mood changes and depression-related reactions can occur, tell your doctor if you feel low, anxious or notice any change in mood. Seek medical attention for thoughts of self-harm. Report any side effect that worries you to your doctor or pharmacist rather than stopping the medicine yourself.
Safety and precautions
Orili 150 is not for use during pregnancy, and pregnancy should be ruled out before starting; if pregnancy occurs during treatment, the medicine should be stopped. It is also not for women with known osteoporosis or severe liver impairment, or those taking certain strong OATP 1B1 inhibitors such as cyclosporine and gemfibrozil. Elagolix can lower bone mineral density, may change menstrual bleeding so that pregnancy is harder to recognise, and can cause mood changes or suicidal thoughts; seek medical help for these. Tell your doctor about liver problems, bone problems, depression or anxiety, and all other medicines, including hormonal contraceptives, before starting.
Frequently asked questions
What is Orili 150 used for, and what kind of medicine is it?
Orili 150 is used for the management of moderate to severe pain associated with endometriosis in women. It is a gonadotropin-releasing hormone (GnRH) antagonist, given as a 150 mg tablet, and it acts on the GnRH receptor involved in the estrogen-dependent growth of endometriosis lesions.
How should Orili 150 be taken?
It is swallowed as a tablet, usually at about the same time each day, with or without food. The doctor decides the dose, how often it is taken and how long the course lasts. Do not change the schedule yourself; ask your doctor or pharmacist if anything is unclear.
What does the generic name elagolix mean?
Elagolix is the generic name of the active ingredient in Orili 150. It is a nonpeptide, small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist taken by mouth. The generic name identifies the medicine itself, while Orili 150 is the brand name under which Square Pharmaceuticals PLC supplies it.
Is Orili 150 safe during pregnancy?
It is not for use in pregnancy, and pregnancy should be excluded before starting treatment. If pregnancy happens while taking it, the medicine should be stopped and the doctor informed. Because it can change menstrual bleeding, pregnancy may be harder to notice, so testing is advised if pregnancy is suspected.
Indications
Pharmacology
Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.
Dosage & Administration
Initiate treatment with Elagolix 150 mg once daily-
- Maximum Treatment Duration: 24 months
- Coexisting Condition: None
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Dyspareunia
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)
Interaction
Contraindications
- Who are pregnant
- Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
- With known osteoporosis because of the risk of further bone loss
- With severe hepatic impairment because of the risk of bone loss
- With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)
Side Effects
Pregnancy & Lactation
There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.
Precautions & Warnings
- Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
- Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
- Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
- Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
- Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.
Overdose Effects
Storage Conditions
Alternative brands of Elagolix
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.